Cargando…

Муковисцидоз как полиэндокринное заболевание (обзор литературы)

The cystic fibrosis transmembrane regulator (CFTR) gene encodes the synthesis of a protein of the same name, which functions as a direct activator of anionic transport. Chloride is the most abundant anion; as an antagonist of Na+ and K+, it provides electroneutrality of cell membranes at rest; toget...

Descripción completa

Detalles Bibliográficos
Autores principales: Чагай, Н. Б., Хайт, Г. Я., Вдовина, Т. М., Шафорост, А. А.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrinology Research Centre 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926149/
https://www.ncbi.nlm.nih.gov/pubmed/34004101
http://dx.doi.org/10.14341/probl12694
_version_ 1784670176998850560
author Чагай, Н. Б.
Хайт, Г. Я.
Вдовина, Т. М.
Шафорост, А. А.
author_facet Чагай, Н. Б.
Хайт, Г. Я.
Вдовина, Т. М.
Шафорост, А. А.
author_sort Чагай, Н. Б.
collection PubMed
description The cystic fibrosis transmembrane regulator (CFTR) gene encodes the synthesis of a protein of the same name, which functions as a direct activator of anionic transport. Chloride is the most abundant anion; as an antagonist of Na+ and K+, it provides electroneutrality of cell membranes at rest; together with cations, it serves as an important osmolyte and forms water flow across cell membranes for transepithelial secretion.Glandular cells in CF trap Cl– and Na+, and the prodused secretion is excessively viscous. Subnormal CFTR activity leads to stagnation of mucociliary clearance, inhibition of intestinal transport.In addition to exocrine disorders, CFTR mutations are associated with a decrease in volume, mass, increased apoptosis of β-cells of the pancreas, a significant suppression of insulin exocytosis in response to stimulation with glucose and glucagon-like peptide-1, hyperglucagonemia against the background of a defect in the suppression of α-cell function by insulin, but a decrease in maximum capacity α-cells.Deficiency and progressive decline in bone mineral density is an expected secondary manifestation of CF due to pancreatic exocrine insufficiency with malabsorption of nutrients and fat-soluble vitamins. However, in patients with the F508del mutation, a significant decrease in the synthesis of OPG, COX-2, PGE2 in the osteoblastic formation, and an increase in the activity of the antianabolic NF-kB were found. We are talking about a defect in the canonical signaling pathway (Wnt/β-catenin), which regulates the expression of genes-activators of osteoblastogenesis, dissociation of the stages of physiological bone remodeling.In addition to congenital bilateral or unilateral aplasia of the vas deferens, an increase in the frequency of CFTR mutations is also found in non-obstructive azoospermia, oligo-, astheno- and teratospermia. CFTR is involved in the entry of HCO3– into Sertoli cells to trigger cAMP-dependent transcription and its defects lead to suppression of FSH-dependent gene expression of spermatogenesis, loss of sequence in the Wnt cascade, destruction of the PGE2-dependent transepithelial interaction and, as a consequence, the blood-testicular barrier.CF is characterized, along with classical signs, by endocrine dysfunction of the pancreas, osteoporosis with suppression of osteoblastogenesis, and a defect in spermatogenesis.
format Online
Article
Text
id pubmed-8926149
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Endocrinology Research Centre
record_format MEDLINE/PubMed
spelling pubmed-89261492022-04-04 Муковисцидоз как полиэндокринное заболевание (обзор литературы) Чагай, Н. Б. Хайт, Г. Я. Вдовина, Т. М. Шафорост, А. А. Probl Endokrinol (Mosk) Research Article The cystic fibrosis transmembrane regulator (CFTR) gene encodes the synthesis of a protein of the same name, which functions as a direct activator of anionic transport. Chloride is the most abundant anion; as an antagonist of Na+ and K+, it provides electroneutrality of cell membranes at rest; together with cations, it serves as an important osmolyte and forms water flow across cell membranes for transepithelial secretion.Glandular cells in CF trap Cl– and Na+, and the prodused secretion is excessively viscous. Subnormal CFTR activity leads to stagnation of mucociliary clearance, inhibition of intestinal transport.In addition to exocrine disorders, CFTR mutations are associated with a decrease in volume, mass, increased apoptosis of β-cells of the pancreas, a significant suppression of insulin exocytosis in response to stimulation with glucose and glucagon-like peptide-1, hyperglucagonemia against the background of a defect in the suppression of α-cell function by insulin, but a decrease in maximum capacity α-cells.Deficiency and progressive decline in bone mineral density is an expected secondary manifestation of CF due to pancreatic exocrine insufficiency with malabsorption of nutrients and fat-soluble vitamins. However, in patients with the F508del mutation, a significant decrease in the synthesis of OPG, COX-2, PGE2 in the osteoblastic formation, and an increase in the activity of the antianabolic NF-kB were found. We are talking about a defect in the canonical signaling pathway (Wnt/β-catenin), which regulates the expression of genes-activators of osteoblastogenesis, dissociation of the stages of physiological bone remodeling.In addition to congenital bilateral or unilateral aplasia of the vas deferens, an increase in the frequency of CFTR mutations is also found in non-obstructive azoospermia, oligo-, astheno- and teratospermia. CFTR is involved in the entry of HCO3– into Sertoli cells to trigger cAMP-dependent transcription and its defects lead to suppression of FSH-dependent gene expression of spermatogenesis, loss of sequence in the Wnt cascade, destruction of the PGE2-dependent transepithelial interaction and, as a consequence, the blood-testicular barrier.CF is characterized, along with classical signs, by endocrine dysfunction of the pancreas, osteoporosis with suppression of osteoblastogenesis, and a defect in spermatogenesis. Endocrinology Research Centre 2021-03-30 /pmc/articles/PMC8926149/ /pubmed/34004101 http://dx.doi.org/10.14341/probl12694 Text en Copyright © Endocrinology Research Centre, 2021 https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 License.
spellingShingle Research Article
Чагай, Н. Б.
Хайт, Г. Я.
Вдовина, Т. М.
Шафорост, А. А.
Муковисцидоз как полиэндокринное заболевание (обзор литературы)
title Муковисцидоз как полиэндокринное заболевание (обзор литературы)
title_full Муковисцидоз как полиэндокринное заболевание (обзор литературы)
title_fullStr Муковисцидоз как полиэндокринное заболевание (обзор литературы)
title_full_unstemmed Муковисцидоз как полиэндокринное заболевание (обзор литературы)
title_short Муковисцидоз как полиэндокринное заболевание (обзор литературы)
title_sort муковисцидоз как полиэндокринное заболевание (обзор литературы)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926149/
https://www.ncbi.nlm.nih.gov/pubmed/34004101
http://dx.doi.org/10.14341/probl12694
work_keys_str_mv AT čagajnb mukoviscidozkakpoliéndokrinnoezabolevanieobzorliteratury
AT hajtgâ mukoviscidozkakpoliéndokrinnoezabolevanieobzorliteratury
AT vdovinatm mukoviscidozkakpoliéndokrinnoezabolevanieobzorliteratury
AT šaforostaa mukoviscidozkakpoliéndokrinnoezabolevanieobzorliteratury